BioCentury | May 24, 2019
Finance

How Europe’s hotspots of innovation could fuel its rise as a global player in new modalities

...LSP, Pfizer Venture Investments, Novartis Venture Fund, Arix Bioscience plc (LSE:ARIX), SV Health Investors LLP, Merck Ventures...
BioCentury | Jun 7, 2018
Financial News

Gimv hires Vanparys as partner

...Bram Vanparys joined Gimv's life sciences team as a partner. He was director at Merck Ventures. BC Staff...
BioCentury | Feb 22, 2018
Finance

Belgian Insights

...at ericpierce@biocentury.com for sponsorship opportunities. Special Thanks to Our Sponsors Gold Sponsors McKinsey & Co. Merck Ventures...
BioCentury | Jan 5, 2018
Financial News

Rewind raises €15.2M series A

...million) on Jan. 4 in a series A round led by Boehringer Ingelheim Venture Fund, Merck Ventures...
BioCentury | Jan 4, 2018
Financial News

Rewind raises €15.2M series A

...€15.2 million ($18.2 million) in a series A round led by Boehringer Ingelheim Venture Fund, Merck Ventures...
BioCentury | Oct 26, 2017
Emerging Company Profile

Taking RNA epigenetics by Storm

...other CROs. The company closed a $16 million series A round in 2016, led by Merck Ventures...
...None Number of employees: 14 Funds raised: £12 million ($15.8 million) Investors: Cambridge Innovation Capital, Merck Ventures...
BioCentury | Sep 22, 2017
Financial News

DNA Script raises EUR11M in series A

...it raised €11 million ($13 million) in a series A round led by Illumina Ventures. Merck Ventures...
BioCentury | Sep 1, 2017
Financial News

Macrophage raises L3M to close L12M series A

...Macrophage Pharma Ltd. (Windsor, U.K.) said it raised £3 million ($3.9 million) from new investor Merck Ventures...
BioCentury | Jul 7, 2017
Company News

Merck KGaA spins out cancer newco iOnctura with partner Cancer Research UK

...Merck KGaA (Xetra:MRK) said that its Merck Ventures arm created immuno-oncology newco iOnctura S.A. (Geneva, Switzerland) with...
...human IgG1 mAb against PD-L1 . The newco was announced in late June. This month, Merck Ventures...
BioCentury | Jun 8, 2017
Finance

The bio-tech bridge

...not yet ready for venture investment. Jasper Bos, VP and head of health care at Merck Ventures...
Items per page:
1 - 10 of 32
BioCentury | May 24, 2019
Finance

How Europe’s hotspots of innovation could fuel its rise as a global player in new modalities

...LSP, Pfizer Venture Investments, Novartis Venture Fund, Arix Bioscience plc (LSE:ARIX), SV Health Investors LLP, Merck Ventures...
BioCentury | Jun 7, 2018
Financial News

Gimv hires Vanparys as partner

...Bram Vanparys joined Gimv's life sciences team as a partner. He was director at Merck Ventures. BC Staff...
BioCentury | Feb 22, 2018
Finance

Belgian Insights

...at ericpierce@biocentury.com for sponsorship opportunities. Special Thanks to Our Sponsors Gold Sponsors McKinsey & Co. Merck Ventures...
BioCentury | Jan 5, 2018
Financial News

Rewind raises €15.2M series A

...million) on Jan. 4 in a series A round led by Boehringer Ingelheim Venture Fund, Merck Ventures...
BioCentury | Jan 4, 2018
Financial News

Rewind raises €15.2M series A

...€15.2 million ($18.2 million) in a series A round led by Boehringer Ingelheim Venture Fund, Merck Ventures...
BioCentury | Oct 26, 2017
Emerging Company Profile

Taking RNA epigenetics by Storm

...other CROs. The company closed a $16 million series A round in 2016, led by Merck Ventures...
...None Number of employees: 14 Funds raised: £12 million ($15.8 million) Investors: Cambridge Innovation Capital, Merck Ventures...
BioCentury | Sep 22, 2017
Financial News

DNA Script raises EUR11M in series A

...it raised €11 million ($13 million) in a series A round led by Illumina Ventures. Merck Ventures...
BioCentury | Sep 1, 2017
Financial News

Macrophage raises L3M to close L12M series A

...Macrophage Pharma Ltd. (Windsor, U.K.) said it raised £3 million ($3.9 million) from new investor Merck Ventures...
BioCentury | Jul 7, 2017
Company News

Merck KGaA spins out cancer newco iOnctura with partner Cancer Research UK

...Merck KGaA (Xetra:MRK) said that its Merck Ventures arm created immuno-oncology newco iOnctura S.A. (Geneva, Switzerland) with...
...human IgG1 mAb against PD-L1 . The newco was announced in late June. This month, Merck Ventures...
BioCentury | Jun 8, 2017
Finance

The bio-tech bridge

...not yet ready for venture investment. Jasper Bos, VP and head of health care at Merck Ventures...
Items per page:
1 - 10 of 32